PubMed · 10120165
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R D Gunn. 1992. Critical issues in system implementation.. https://pubmed.ncbi.nlm.nih.gov/10120165/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A survey was conducted of radiology practices with productivity data from at least 3 of the following 4 workflows: film with manual transcription, filmless with manual transcription, film with speech recognition, and filmless with speech recognition. Two surveys were submitted to candidate sites. The first was used to ascertain suitable available data for follow-up. The second survey requested data for report turn around times, full-time equivalent (FTE) staffing levels, and report volume. Data were collected and stored in a Microsoft Access database and statistical analysis performed in Excel. Whereas several metrics were used, the normalized figure of reports-per-day/FTE was found to have improved an average of 1.9 (for filmless with speech recognition) and 2.3 (for film with speech recognition) over the film with manual transcription case. Filmless with manual transcription was only 1.4 times the value of the all manual case. At the 10% confidence level, both filmless with manual transcription and film with speech recognition workflows were found to have statistically significant enhanced productivity. Insufficient data exist to show if the fully automated workflow (filmless with speech recognition) offers benefits over 2 previous semiautomated workflows.
Explore the source record for details and available documents.
BACKGROUND: Previous studies concluded that healthy kidney donors should be able to obtain life insurance at standard rates. However, we have become aware of a few donors for whom this was not the case. Clearly, this important issue needs to be readdressed. METHODS: To investigate how American life insurance companies currently view and treat living kidney donors, we mailed a survey to the medical directors of 70 U.S. life insurance companies in the winter of 2001; we included the 20 largest companies ranked by assets. RESULTS: Thirty-eight companies, including 16 of the top 20, chose to participate. All of them said they would offer life insurance to a healthy kidney donor and only one believed it might raise the premium. Only one company thought that kidney donation might adversely affect longevity, and a majority of the companies did not consider healthy donors to be at increased risk for future medical problems. CONCLUSIONS: These data suggest that most life insurance companies are still willing to insure healthy kidney donors at standard rates. Nevertheless, occasional donors may encounter difficulty when applying for life insurance. When this occurs, transplant centers should be prepared to help the donor obtain insurance.